Top Six Thought Leader Liaison Challenges ( 57:37 )
Wed Jan 22nd, 2014

Public scrutiny regarding relationships between thought leaders and drug makers has reached a boiling point. Changes in various policies and regulations have altered the nature of physician-industry relationships, especially compensation.

Elio Evangelista has studied medical affairs groups since joining Cutting Edge Information in 2002. He has built his expertise around fair-market value compensation for thought leaders, MSL program operations, continuing medical education support, publications processes and the effects of regulatory change on medical teams.